Process Development Engineer I
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Process Development Engineer I to join our Purification Development group, supporting our Preclinical Manufacturing & Process Development (PMPD) organization in Tarrytown, NY in an on-site work model. In this role, you will design, deploy, and continuously improve custom automated systems that reduce manual work and improve data accessibility, while collaborating with process development, engineering, and data teams.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Process Development Engineer I to join our Purification Development group, supporting our Preclinical Manufacturing & Process Development (PMPD) organization in Tarrytown, NY in an on-site work model. In this role, you will design, deploy, and continuously improve custom automated systems that reduce manual work and improve data accessibility, while collaborating with process development, engineering, and data teams.
Discover your role
- Design, build, and deploy custom automation solutions for laboratory and pilot-scale process development equipment
- Partner with internal stakeholders to identify bottlenecks and define requirements
- Take projects from concept through design, procurement, controls development, testing, and technology transfer
- Develop control logic, HMIs, and supporting software for automated systems
- Maintain and enhance existing systems to improve reliability, scalability, and usability
- Integrate equipment with data platforms and PI historian to enable monitoring, trending, and reporting
- Troubleshoot automation and communication issues across devices, control systems, and data infrastructure
- Document system designs and present progress to cross-functional teams
This role requires
- Bachelor's or Master's degree in Engineering (Chemical, Mechanical, Electrical, Biomedical) or a related field with 0–2 years of experience
- Strong background in either downstream bioprocessing (filtration, chromatography, pilot-scale operations) or automation, controls, or software development
- Strong problem-solving, communication, and troubleshooting skills
- Manage multiple projects and priorities at once, motivated to reduce manual work and make data more accessible
- Collaborate easily across software, electrical, mechanical, and process development disciplines
- Preferred: experience with industrial automation and control systems, including control logic (sequential function charts, state-based control) and programming (Python)
- Preferred: familiarity with industrial communication protocols (OPC, Modbus TCP), SCADA/HMI platforms (Ignition), and data historians (AVEVA PI)
Requirements
- Bachelor's or Master's degree in Engineering (Chemical, Mechanical, Electrical, Biomedical) or a related field
- 0–2 years of experience
- Strong background in downstream bioprocessing (filtration, chromatography, pilot-scale operations) or automation, controls, or software development
- Strong problem-solving, communication, and troubleshooting skills
- Ability to manage multiple projects and priorities at once
- Collaborate easily across software, electrical, mechanical, and process development disciplines
- Preferred: experience with industrial automation and control systems, including control logic (sequential function charts, state-based control) and programming (Python)
- Preferred: familiarity with industrial communication protocols (OPC, Modbus TCP), SCADA/HMI platforms (Ignition), and data historians (AVEVA PI)
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.